Write For Us

Precision Medicine: Progress and Promise

E-Commerce Solutions SEO Solutions Marketing Solutions
189 Views
Published
As genomic technologies move from lab to clinic, how can business and government bridge the gap between availability and access?

Dimensions to be addressed:
- Health system infrastructure
- Data on clinical and cost effectiveness
- Lagging insurance models

Speakers:
- Jay Flatley, Executive Chairman, Illumina, USA.
- Elisabet de los Pinos Pont, Founder and Chief Executive Officer, Aura Biosciences, USA.
- Wang Jian, President and Co-Founder, BGI, People's Republic of China.

Moderated by:
- Mariette DiChristina, Editor-in-Chief, Scientific American, USA.

http://www.weforum.org/
Category
Success
Sign in or sign up to post comments.
Be the first to comment